193 related articles for article (PubMed ID: 17169360)
1. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.
Sahin U; Blobel CP
FEBS Lett; 2007 Jan; 581(1):41-4. PubMed ID: 17169360
[TBL] [Abstract][Full Text] [Related]
2. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
[TBL] [Abstract][Full Text] [Related]
3. Different ADAMs have distinct influences on Kit ligand processing: phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19.
Kawaguchi N; Horiuchi K; Becherer JD; Toyama Y; Besmer P; Blobel CP
J Cell Sci; 2007 Mar; 120(Pt 6):943-52. PubMed ID: 17344430
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
5. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
6. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.
Li X; Maretzky T; Weskamp G; Monette S; Qing X; Issuree PD; Crawford HC; McIlwain DR; Mak TW; Salmon JE; Blobel CP
Proc Natl Acad Sci U S A; 2015 May; 112(19):6080-5. PubMed ID: 25918388
[TBL] [Abstract][Full Text] [Related]
7. EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments.
Kataoka H
J Dermatol Sci; 2009 Dec; 56(3):148-53. PubMed ID: 19896805
[TBL] [Abstract][Full Text] [Related]
8. Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution.
Myhre GM; Toruner M; Abraham S; Egan LJ
Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1213-9. PubMed ID: 15284022
[TBL] [Abstract][Full Text] [Related]
9. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.
Le Gall SM; Bobé P; Reiss K; Horiuchi K; Niu XD; Lundell D; Gibb DR; Conrad D; Saftig P; Blobel CP
Mol Biol Cell; 2009 Mar; 20(6):1785-94. PubMed ID: 19158376
[TBL] [Abstract][Full Text] [Related]
10. PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.
Kveiborg M; Instrell R; Rowlands C; Howell M; Parker PJ
PLoS One; 2011 Feb; 6(2):e17168. PubMed ID: 21386996
[TBL] [Abstract][Full Text] [Related]
11. The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.
Chen R; Jin G; McIntyre TM
J Biol Chem; 2017 Jun; 292(24):10112-10122. PubMed ID: 28455445
[TBL] [Abstract][Full Text] [Related]
12. ADAMs and protein disulfide isomerase: the key to regulated cell-surface protein ectodomain shedding?
Bass R; Edwards DR
Biochem J; 2010 May; 428(3):e3-5. PubMed ID: 20504280
[TBL] [Abstract][Full Text] [Related]
13. Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain.
Lorenzen I; Trad A; Grötzinger J
Biochem Biophys Res Commun; 2011 Nov; 415(2):330-6. PubMed ID: 22033402
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
15. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
[TBL] [Abstract][Full Text] [Related]
16. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
[TBL] [Abstract][Full Text] [Related]
17. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability?
Melenhorst WB; Visser L; Timmer A; van den Heuvel MC; Stegeman CA; van Goor H
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F781-90. PubMed ID: 19535569
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulus.
Dang M; Dubbin K; D'Aiello A; Hartmann M; Lodish H; Herrlich A
J Biol Chem; 2011 May; 286(20):17704-13. PubMed ID: 21454702
[TBL] [Abstract][Full Text] [Related]
19. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin.
Nakayama H; Fukuda S; Inoue H; Nishida-Fukuda H; Shirakata Y; Hashimoto K; Higashiyama S
Mol Biol Cell; 2012 May; 23(10):1964-75. PubMed ID: 22438584
[TBL] [Abstract][Full Text] [Related]
20. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.
Dang M; Armbruster N; Miller MA; Cermeno E; Hartmann M; Bell GW; Root DE; Lauffenburger DA; Lodish HF; Herrlich A
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9776-81. PubMed ID: 23720309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
